242 related articles for article (PubMed ID: 25087836)
1. Minimal important difference in field walking tests in non-cystic fibrosis bronchiectasis following exercise training.
Lee AL; Hill CJ; Cecins N; Jenkins S; McDonald CF; Burge AT; Rautela L; Stirling RG; Thompson PJ; Holland AE
Respir Med; 2014 Sep; 108(9):1303-9. PubMed ID: 25087836
[TBL] [Abstract][Full Text] [Related]
2. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease.
Holland AE; Hill CJ; Rasekaba T; Lee A; Naughton MT; McDonald CF
Arch Phys Med Rehabil; 2010 Feb; 91(2):221-5. PubMed ID: 20159125
[TBL] [Abstract][Full Text] [Related]
3. Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy.
Zanini A; Aiello M; Adamo D; Cherubino F; Zampogna E; Sotgiu G; Chetta A; Spanevello A
Respiration; 2015; 89(6):525-33. PubMed ID: 25924686
[TBL] [Abstract][Full Text] [Related]
4. Field Walking Tests Are Reliable and Responsive to Exercise Training in People With Non-Cystic Fibrosis Bronchiectasis.
Lee AL; Cecins N; Holland AE; Hill CJ; McDonald CF; Burge AT; Rautela L; Thompson PJ; Stirling RG; Jenkins S
J Cardiopulm Rehabil Prev; 2015; 35(6):439-45. PubMed ID: 26252343
[TBL] [Abstract][Full Text] [Related]
5. Effects of pulmonary rehabilitation in bronchiectasis: A retrospective study.
Ong HK; Lee AL; Hill CJ; Holland AE; Denehy L
Chron Respir Dis; 2011; 8(1):21-30. PubMed ID: 21339371
[TBL] [Abstract][Full Text] [Related]
6. Incremental shuttle walking test: a reproducible and valid test to evaluate exercise tolerance in adults with noncystic fibrosis bronchiectasis.
de Camargo AA; Amaral TS; Rached SZ; Athanazio RA; Lanza FC; Sampaio LM; de Carvalho CR; Cukier A; Stelmach R; Dal Corso S
Arch Phys Med Rehabil; 2014 May; 95(5):892-9. PubMed ID: 24361325
[TBL] [Abstract][Full Text] [Related]
7. The incremental shuttle walk test in older Brazilian adults.
Jürgensen SP; Antunes LC; Tanni SE; Banov MC; Lucheta PA; Bucceroni AF; Godoy I; Dourado VZ
Respiration; 2011; 81(3):223-8. PubMed ID: 20639622
[TBL] [Abstract][Full Text] [Related]
8. Small changes in six-minute walk distance are important in diffuse parenchymal lung disease.
Holland AE; Hill CJ; Conron M; Munro P; McDonald CF
Respir Med; 2009 Oct; 103(10):1430-5. PubMed ID: 19477109
[TBL] [Abstract][Full Text] [Related]
9. Clinical determinants of the 6-Minute Walk Test in bronchiectasis.
Lee AL; Button BM; Ellis S; Stirling R; Wilson JW; Holland AE; Denehy L
Respir Med; 2009 May; 103(5):780-5. PubMed ID: 19070473
[TBL] [Abstract][Full Text] [Related]
10. The minimum clinically important improvement in the incremental shuttle walk test following cardiac rehabilitation.
Houchen-Wolloff L; Boyce S; Singh S
Eur J Prev Cardiol; 2015 Aug; 22(8):972-8. PubMed ID: 24958737
[TBL] [Abstract][Full Text] [Related]
11. Minimal important difference of the 6-minute walk distance in lung cancer.
Granger CL; Holland AE; Gordon IR; Denehy L
Chron Respir Dis; 2015 May; 12(2):146-54. PubMed ID: 25749346
[TBL] [Abstract][Full Text] [Related]
12. Exercise training and inspiratory muscle training in patients with bronchiectasis.
Newall C; Stockley RA; Hill SL
Thorax; 2005 Nov; 60(11):943-8. PubMed ID: 15994254
[TBL] [Abstract][Full Text] [Related]
13. Minimum clinically important improvement for the incremental shuttle walking test.
Singh SJ; Jones PW; Evans R; Morgan MD
Thorax; 2008 Sep; 63(9):775-7. PubMed ID: 18390634
[TBL] [Abstract][Full Text] [Related]
14. Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis.
Nathan SD; du Bois RM; Albera C; Bradford WZ; Costabel U; Kartashov A; Noble PW; Sahn SA; Valeyre D; Weycker D; King TE
Respir Med; 2015 Jul; 109(7):914-22. PubMed ID: 25956020
[TBL] [Abstract][Full Text] [Related]
15. Interpretation of treatment changes in 6-minute walk distance in patients with COPD.
Puhan MA; Mador MJ; Held U; Goldstein R; Guyatt GH; Schünemann HJ
Eur Respir J; 2008 Sep; 32(3):637-43. PubMed ID: 18550610
[TBL] [Abstract][Full Text] [Related]
16. Significance of changes in endurance shuttle walking performance.
Pepin V; Laviolette L; Brouillard C; Sewell L; Singh SJ; Revill SM; Lacasse Y; Maltais F
Thorax; 2011 Feb; 66(2):115-20. PubMed ID: 21148135
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the need for two incremental shuttle walk tests during a maintenance exercise program in people with COPD.
Spencer LM; Alison JA; McKeough ZJ
Physiotherapy; 2014 Jun; 100(2):123-7. PubMed ID: 24690443
[TBL] [Abstract][Full Text] [Related]
18. Six-minute walk distance is not related to quality of life in patients with non-cystic fibrosis bronchiectasis.
Jacques PS; Gazzana MB; Palombini DV; Barreto SS; Dalcin Pde T
J Bras Pneumol; 2012; 38(3):346-55. PubMed ID: 22782605
[TBL] [Abstract][Full Text] [Related]
19. Effects of inspiratory muscle thixotropy on the 6-min walk distance in COPD.
Izumizaki M; Satake M; Takahashi H; Sugawara K; Shioya T; Homma I
Respir Med; 2008 Jul; 102(7):970-7. PubMed ID: 18396028
[TBL] [Abstract][Full Text] [Related]
20. The minimal detectable difference for endurance shuttle walk test performance in people with COPD on completion of a program of high-intensity ground-based walking.
Hill K; Ng C; Wootton SL; McKeough ZJ; Eastwood PR; Hillman DR; Jenkins C; Spencer L; Jenkins SC; Cecins NM; Alison JA
Respir Med; 2019 Jan; 146():18-22. PubMed ID: 30665513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
